Updates are available Correction dated 2022-12-05
Click to view Correction: https://doi.org/10.1038/s41380-022-01895-y
-
Authors
Pagano, Roberto http://orcid.org/0000-0003-3310-2903
Salamian, Ahmad http://orcid.org/0000-0003-2841-9228
Zielinski, Janusz
Beroun, Anna
Nalberczak-Skóra, Maria
Skonieczna, Edyta
Cały, Anna http://orcid.org/0000-0002-7687-4471
Tay, Nicole http://orcid.org/0000-0002-1307-408X
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Desrivières, Sylvane
Grigis, Antoine
Garavan, Hugh
Heinz, Andreas http://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger http://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc http://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère http://orcid.org/0000-0002-0452-2450
Artiges, Eric http://orcid.org/0000-0003-4461-7646
Nees, Frauke http://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos http://orcid.org/0000-0002-1242-8990
Poustka, Luise
Hohmann, Sarah
Fröhner, Juliane H. http://orcid.org/0000-0002-8493-6396
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert http://orcid.org/0000-0002-2790-7281
Kalita, Katarzyna
Bito, Haruhiko http://orcid.org/0000-0001-6315-9594
Müller, Christian P. http://orcid.org/0000-0002-5325-9900
Schumann, Gunter http://orcid.org/0000-0002-7740-6469
Okuno, Hiroyuki http://orcid.org/0000-0001-6237-6503
Radwanska, Kasia http://orcid.org/0000-0001-7445-6180
,
- License Information
-
More Information
Article History
Received: 1 August 2022
Revised: 12 October 2022
Accepted: 18 October 2022
First Online: 10 November 2022
Change Date: 5 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-022-01895-y
Competing interests
: TB served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Janssen, Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Dr Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. LP served in an advisory or consultancy role for Roche and Viforpharm and received a speaker’s fee from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential competing interests.
